Tag Archives: clinical trials

A research team from Colorado State University has found that drugs used to treat malaria are also effective in treating a lung disease similar to tuberculosis. Their findings were featured on the cover of the February 23 issue of Science Translational Medicineone of the best scientific journals in the country. …

Medical Design & Manufacturing (MD&M) West, the largest medtech event in North America and hosted annually by Informa Markets – Engineering, unveils its educational programming for Design. Engineer. To construct. Conference. Speakers include experts from Medtronic, NXT Biomedical, Canary Medical, Galen Robotics, Edward Life Sciences, Philips, Tech Coast Angels, Stryker, …

BALTIMORE, March 3, 2022—The University of Maryland School of Medicine Institute of Human Virologya Global Virus Network (GVN) Center of excellence, physician researchers played a collaborative role in the successful transplant last month of a genetically modified pig heart into a patient with end-stage heart disease by creating strategies for …

February 18, 2022 4 minute read Source/Disclosures Published by: Source: Knudsen KE. A way forward, a call to action: Addressing trends and disparities in genitourinary cancers. Presented at: ASCO Genitourinary Cancer Symposium; February 17-19, 2022; San Francisco. Disclosures: Knudsen does not report any relevant financial information. …

DENVER, February 17, 2022 /PRNewswire/ — Dialysis patients who received an adenovirus vector-based COVID-19 vaccine (Johnson & Johnson) had similar rates of breakthrough infection, hospitalization and mortality as dialysis patients who received a mRNA-based vaccine (Pfizer/BioNTech), according to a DaVita Clinical Research (DCR) study published online ahead of print by …

Cymbeline “Bem” Culiat, co-founder, president and chief scientific officer of NellOne Therapeutics Inc. in Knoxville and former molecular geneticist at Oak Ridge National Laboratory, will speak virtually to Friends of ORNL at noon on Tuesday, February 8. She will talk about “Future Applications in Regenerative Medicine” and part of her …

WORCESTER, Mass., Jan. 7, 2022 (GLOBE NEWSWIRE) – Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs into therapies cells and genes in potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced that interim phase 1/2 data on MB-106, …

Via repositioning the drug, Osaka City University creates a combination of rifampin and resveratrol and has shown in mouse models that nasal administration improves cognitive function without the negative liver side effects of rifampin only. Via repositioning the drug, Osaka City University creates a combination of rifampin and resveratrol and …

As researchers have identified several genes responsible for prostate cancer, a new study published in Nature reveals the puppeteer controlling the strings. The chains: carcinogenic or oncogenic genes, such as the androgen receptor, FOXA1, ERG and MYC. The Puppet Master: A chromatin remodeling complex called SWI / SNF, which controls …

WASHINGTON and SOUTH SAN FRANCISCO, California, December 2, 2021 / PRNewswire / – The ASH Research Collaborative (ASH RC), a nonprofit organization established in 2018 by the American Society of Hematology (ASH) and Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) has announced today that GBT will provide a grant of …

How far would you go to save your child’s life? Haoyang was born in Kunming in southwest China two years ago with a very rare disease: Menkes syndrome. The disease is a genetic disease that impacts how copper – which is crucial for brain and nervous system development – is …

As we move towards the second anniversary of the COVID-19 pandemic, attention widens to encompass the range of unintended health care consequences of these unprecedented times and measures. Against this background, efforts have been made to analyze the data and predict what the winter months will look like in terms …

Two days after testing positive for COVID-19, Green Bay Packers quarterback Aaron Rodgers joined the “Pat McAfee Show” on Friday to explain his decision not to take one of the COVID-19 vaccines. Rodgers described himself as not “some kind of anti-vax, flat earth” but rather “a critical thinker”. He referred …

A genetic biomarker test for patients with aggressive prostate cancer has identified patients most likely to respond to radiation and hormone therapy or to develop metastases, allowing providers to tailor treatment regimens to high risk patients. A genetic biomarker test has been shown to accurately predict how men with high-risk …

GAINESVILLE, Florida – (COMMERCIAL THREAD) –Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical-stage biotechnology company dedicated to the development of life-changing drugs through science and innovation for patients and families living with diseases, today announced the appointment of Cynthia A. Lemere, PhD as Senior Advisor for …

“It was a good marriage for both of you,” said Lorne Tyrrell, co-director of the institute and discoverer of the first oral treatment for hepatitis B. Canada currently does not have the capacity to manufacture its own supply of drugs, a gap that became evident when the federal government attempted …

WOODBURY, Minnesota – (BUSINESS WIRE) – October 28, 2021– The American Society of Regional Anesthesia has selected the INSB200 â„¢ poster from InSitu Biologics as its The best of the meeting presentation in Emerging Technologies for their 20 th Annual Pain Meeting in November 2021. The “Best of Meeting” award …

UNIVERSITY PARK, Pa .– A protein can be used to recover and purify radioactive metals such as actinium that could be beneficial for next-generation drugs used in cancer therapies and medical imaging, according to new research from Penn State and Lawrence Livermore National Laboratory (LLNL). Radioactive metals are used in …

CARLSBAD, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) – Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with orphan drug designation potential, announces today the publication of a study in the open source peer-reviewed journal, Diagnostic, validating the FastPack of the Company’s …

JoAnn Trejo, PhD, MBA, Professor in the Department of Pharmacology, UC San Diego School of Medicine and Assistant Vice Chancellor of Affairs, UC San Diego School of Health Sciences, and Elizabeth Winzeler, PhD , Professor in the Division of Host Microbial Systems and Therapeutics in the Department of Pediatrics, UC …

How would you go about solving a puzzle if you didn’t know which pieces to use, how many you would need, what it was supposed to look like when finished, or what function it could serve? Such a challenge was taken up by Frank Graham in 1969 when he was …

In his 2020 Presidential Address for the American Society of Clinical Oncology, “Equity: Every patient. Everyday. Everywhere, ”Lori J. Pierce, MD, challenges medical oncology to imagine a future where fairness is seen as a humanistic standard of oncology practice. In his 2020 Presidential Address for the American Society of Clinical …

CALGARY, Alberta, October 14, 2021 (GLOBE NEWSWIRE) – XORTX Therapeutics Inc. (“XORTX“or the”Society“) (CSE: XRX | NASDAQ: XRTX), a therapeutic pharmaceutical company focused on developing innovative therapies to treat progressive renal failure, is pleased to announce and share the results of a summary of the American Society of Nephrology Kidney …

Developing countries increasingly turn to local vaccinations against Covid as UN receives support Covax program is behind schedule. As Western countries roll out booster injections to their own populations, Covax, which has been set up by United Nations agencies, governments and donors to ensure equitable access to Covid-19 vaccines for …

As part of our “Meet Yale Internal Medicine” series, today’s featured physician is Meghana Rao Brito, MD, Assistant Professor of Clinical Medicine (Cardiovascular Medicine). An interest in medicine began early for Meghana Rao Brito, MD. “It sounds a bit cliché, but I really became fascinated by the world of medicine …

Dublin, October 08, 2021 (GLOBE NEWSWIRE) – The Clinical Trial Kits Market Size, Share and Trend Analysis Report by Department (Kit Solutions, Logistics), by Phase (Phase I, Phase II, Phase III, Phase IV), by Region and segment forecast, 2021-2028 “ report was added to ResearchAndMarkets.com offer. The global clinical trial …

Denali Therapeutics Announces Positive Clinical Results and Regulatory Advances for Developmental Programs in Amyotrophic Lateral Sclerosis (ALS) Details Category: Small Molecules Posted on Thursday 07 October 2021 11:15 Hits: 68 The eIF2B DNL343 activator achieved safety and biomarker objectives in a phase 1 study in healthy volunteers; a phase 1b …

TOULOUSE, France & LAKELAND, Michigan, October 07, 2021– (BUSINESS WIRE) – Regulatory news: ABIONYX Pharma (Paris: ABNX) (FR0012616852 – ABNX – PEA PME eligible), a new generation biotechnology company dedicated to the discovery and development of innovative therapies, announces today, after having already obtained an orphan drug designation for CER-001 …

Clinical trials are underway after scientists using the advanced photon source discovered that lasofoxifene may be a safer and more effective treatment for breast cancer than the current gold standard. In 2020, 2.3 million women worldwide were diagnosed with breast cancer, according to the World Health Organization, and the disease …

Bio-printers that allow scientists to design complex tissues and organs. It sounds like science fiction, but not to scientists at the Alireza Mashaghi lab at the Leiden Academic Center for Drug Research. The laboratory was recently equipped with two state-of-the-art bio-printers: BioX and LumenX +. 3D and 4D bio-printed fabrics …

The United Arab Emirates became the second country in the world, after the United States, to approve the registration and use of Biogen’s Aduhelm (aducanumab), the first and only drug to treat the early stages of cancer. Alzheimer’s disease. The drug is supplied in the form of injections containing a …

Glioblastoma is one of the deadliest cancers known to man. While the advent of immunotherapy and other cutting-edge treatments have extended the lives of people with other types of cancer, the prognosis for glioblastoma has remained relatively constant – just 18 months. This year and a half can be brutal: …

The United Arab Emirates became the second country in the world to approve the use of the first and only drug for the treatment of early stages of Alzheimer’s disease. On Sunday, the Department of Health and Prevention (MoHAP) announced that it had obtained the green light for the registration …

The Covid-19 pandemic has slowed the progress of cancer research that has taken place over the past two decades, but some clinical trials have continued despite the limits of the pandemic – according to the Cork-based oncologist, Dr Richard Bambury. Dr Bambury said Irish Medical Time that in cancer research, …

A drug candidate discovered and developed decades ago in the lab of distinguished professor Bruce Hammock at UC Davis could help control the body’s raging and often fatal inflammatory response to chemotherapy treatments, especially for patients with pancreatic and liver cancer. The research team, based in Dipak Panigrahy’s labs at …

An international group of cancer researchers, led by the Cellular Molecular Pathology Initiative (CMPath) at the National Cancer Research Institute (NCRI), has published guidance for addressing variability in how pathology is planned and delivered in clinical trials. The guide, which was published today in The Lancet Oncology, was produced through …

NEW YORK, September 27, 2021 / PRNewswire / – Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (“Actinium” or the “Company”), a leader in the development of targeted radiation therapy for patients with unmet needs, today announced several updates on its R&D capabilities. Actinium recently completed the expansion of its New York …

An international team of scientists created a three-dimensional (3D) model of pancreatic cancer tumor in the laboratory, combining a bioengineered matrix and cells derived from patients that could be used to develop and test targeted treatments. In a new study published today in Nature Communication, researchers from the University of …

The locus coeruleus (LC) is a tiny region of the brain that plays a disproportionate role in the functioning of our central nervous system. The name of LC comes from Latin for blue spot, its notable color is the product of intense chemical activity. This activity produces the main brain …

New research indicates that fecal microbiota transplantation (FMT) is a viable treatment option for recurrent Clostridioides difficile infections (CDI), but less so for primary CDI. A team, led by Tanveer Singh, MD, MBBS, Departments of Medicine, Cleveland Clinic, evaluated the effectiveness of fecal microbiota transplantation versus medical treatment. Therapy Various …

BOSTON–(COMMERCIAL THREAD) – SmartLabs, a Boston-based leader in Lab as a Service (LaaS), today announced it has raised a Series B funding of $ 250 million. The funding round was led by ArrowMark Partners. New investment partners include Winslow Capital Management and Onex Falcon, joined by existing investors ArrowMark Partners, …

Key Partnership to Connect Patients to Precision Oncology Clinical Trials and New Therapies, Accelerating Access to Promising Treatments SCOTTSDALE, Arizona, September 16, 2021– (BUSINESS WIRE) – Translational Drug Development (TD2), a leading precision oncology contract research organization (CRO), and Deep Lens have announced a strategic partnership that will improve access …

The 2019 coronavirus disease (COVID-19) pandemic has infected an estimated 225 million people and killed more than 4.64 million worldwide. This pandemic is caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which was first reported in Wuhan, China in 2019. Study: Therapeutic efficacy of an oral nucleoside analog of …

Korean manufacturers of artificial intelligence-based medical equipment have increased their global presence through superior technologies. Many companies use AI platforms to diagnose cancer. However, Deep Bio wants to make a difference by diagnosing prostate cancer using AI for the first time in Korea. In April of last year, Deep Bio …

Researchers at Vanderbilt Diabetes Research and Training Center (DRTC) at Vanderbilt University Medical Center conducted a multi-site study that demonstrated that, when controlled and standardized, quantitative magnetic resonance imaging (MRI) of the pancreas is highly reproducible when using different MRI hardware and software in different geographic locations. This discovery opens …

Antibodies that bind to semen could be an effective non-hormonal method of birth control, at least according to early studies in sheep, the researchers report. When researchers introduced modified human anti-sperm antibodies into sheep’s vaginas, they found a 99.9% drop in moving sperm, according to a report in Science Translational …

Amid a COVID-19 pandemic well into its second year, most developed countries are implementing effective vaccination campaigns against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) to reduce the spread of the infection. In December 2020, the Food and Drug Administration granted emergency use of two messenger RNA (mRNA) vaccines developed …

News desk @ bactiman63 Lyme Bay Region Foundation, a major sponsor of Lyme disease research in the United States, today announced the publication of new data showing that herbal drugs have potent activity in test tubes compared to commonly prescribed pharmaceuticals for the treatment of Bartonella henselae, a bacteria believed …

It is difficult to diagnose a rare disease. Identifying a treatment can take years of trial and error. At the fortuitous intersection of research expertise, a sick patient in this case a child, and innovative technology, Bachmann-Bupp syndrome has gone from a list of symptoms to a treatment. succeeded in …

MARLBOROUGH, Mass., July 19, 2021 (GLOBE NEWSWIRE) – Akoya Biosciences Inc, (Nasdaq: AKYA) The Spatial Biology Company®, today announced that the Phenoptics â„¢ mIF solution has been used in a multi-site study to demonstrate and validate an automated end-to-end workflow that characterizes PD-1 / PD-L1 immune checkpoint signaling in tumor …

Nature Medicine publication shows neutralizing antibodies are essential in preventing or reducing the severity of COVID-19 infection, including infection with emerging variants of COVID-19 such as the Delta variant, for vaccinated populations and not vaccinated Todos now validates cPass in its highly automated CLIA / CAP lab at Provista Diagnostics …

In this study, published in the Journal of the American Society of Nephrology, the researchers studied patients at nephrology clinics in Brazil, France, the United States and Germany to assess a possible independent association of iron store anemia in patients with or without the disease and not on dialysis on …

The study “shows that measurement with a urine test offers improved accuracy compared to other measurement methods, for example certain types of blood tests,” said a press release from KI. Researchers from Karolinska Institute (KI) in Sweden have developed a non-invasive urine test that can identify which type of asthma …

STELFONTA® is indicated for the treatment of non-metastatic (WHO stage), cutaneous (located anywhere on the body, legs or head in dogs), and non-metastatic subcutaneous MCTs located in dogs. or downstream of the elbow or hock in dogs. Tumors can be of any cytological grade, should be less than or equal …

WASHINGTON, July 1, 2021 / PRNewswire / – The AACC, a global scientific and medical professional organization dedicated to improving health through laboratory medicine, is pleased to announce that the impact factor and immediacy index of its journal Clinical chemistry increased to 8.327 and 8.729, respectively, in the 2020 Clarivate …

As the ravages of the opioid epidemic lead many to avoid these potent pain relievers, a significant number of people with fibromyalgia are finding an effective replacement in products containing CBD, a new discovery finds Michigan Medicine Study. CBD, short for cannabidiol, is the second most common cannabinoid in the …

New York, June 22, 2021 (GLOBE NEWSWIRE) – Reportlinker.com announces the publication of the report “Kidney Cancer Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030” – https://www.reportlinker.com / p06097027 /? utm_source = GNW $ 3 billion in 2020 to $ 3.29 billion in 2021 at a compound …

Antibody-based COVID-19 therapies are often given to patients who are at high risk of serious illness and hospitalization. However, there have been nagging questions about whether these antibody therapies retain their effectiveness as disturbing new viral variants emerge. New research at the Washington University School of Medicine in St. Louis …

Scientists have identified a new class of targeted cancer drugs that offer the potential to treat patients whose tumors have defective copies of the BRCA cancer genes. The drugs, known as POLQ inhibitors, specifically kill cancer cells with mutations in BRCA genes while leaving healthy cells unharmed. Most importantly, they …

Treatment options for deadly liver cancer, fibrolamellar carcinoma, are sorely lacking. Drugs that work on other liver cancers are not effective, and although progress has been made in identifying the specific genes involved in the growth of fibrolamellar tumors, these findings have yet to be translated into treatment. For now, …

PPRESS RELEASE Immunocore presentclinical The data further characterizing the overall survival benefit of tebentafuspin metastatic uveal melanoma at 2021 American Society of Clinical Oncology (ASCO) Annual Meeting (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Maryland, United States, June 04, 2021) Immunocore (Nasdaq: IMCR), an advanced biotechnology company pioneering the development …

SEATTLE – (COMMERCIAL THREAD) –Seattle Cancer Care Alliance (SCCA) today announced presentations from the organization’s clinicians to be presented at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting from June 4 to 8, 2021. SCCA clinicians have contributed to studies of several types of cancer spanning the entire …

A new finding in Ewing’s sarcoma, an aggressive and often fatal childhood cancer, has revealed the potential to prevent cancer cells from spreading beyond their primary tumor site. This breakthrough provides new insight into what triggers the process that allows cancer cells to survive while traveling through the body in …

During the pandemic, the diagnostics industry faced many challenges. From logistics to phlebotomists and technicians to technology, the diagnostic industry depends on different vendors to provide phlebotomists, logistics, lab technicians, technology and other services. Established in 2012 with the vision to become the leading healthcare logistics company in India, Credent …

Representative image (IANS) US researchers have developed a new drug that could not only prevent SARS-CoV-2 and its variants, but also treat other respiratory coronaviruses in mice. A team led by the University of Pennsylvania developed the drug diABZI, which activated the body’s innate immune response and effectively prevented severe …

At the end Reported on the fate of stem cell therapies For rare childhood diseases, we noted that a biotechnology company funded by the California Stem Cell Program to monitor treatment development had put the project on hold indefinitely. This is no longer the case. Orchard Therapeutics announced on Friday: …

DUBLIN, May 28, 2021 / PRNewswire / – Alkermes plc (Nasdaq: ALKS) announced today that it will host a webcast and conference call at 4:00 p.m. ET (9:00 p.m. BST) at Friday June 4, 2021 to review data updates presented at the 2021 American Society of Clinical Oncology (ASCO) Annual …

Imagine this scenario: A patient presents to a doctor with a constellation of symptoms and physical traits that at first glance do not lead to an obvious diagnosis. Perhaps the patient has facial abnormalities and heart symptoms, as well as other issues with the skeleton and joints. The provider suspects …

May 25, 2021 – Developing ‘smart toilet’ uses artificial intelligence to analyze stool for consistency and presence of blood – and early evidence suggests more accurate than patient self-report . Remote, automated, real-time analysis and reporting increases the likelihood that doctors will detect gastrointestinal problems sooner, investigators say. In a …

FLORHAM PARK, NJ, May 24, 2021 (GLOBE NEWSWIRE) – PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on proprietary software from the company Versamune® T Cell Activation Technology, today announced that it will host a conference call with the company on June 8, 2021 …

Developing ‘smart toilet’ uses artificial intelligence (AI) to analyze stool for consistency and the presence of blood – and early evidence suggests it’s more accurate than patient self-report , a study reveals. Remote, automated, real-time analysis and reporting increases the likelihood that doctors will detect gastrointestinal (GI) problems sooner, investigators …

A Professional Nurse – Clinical Trials position (one year contract) is available with our client, Clinical Laboratory Services (CLS) of the Wits Health Consortium in Braamfontein, Johannesburg – Gauteng. Background Clinical Laboratory Services (CLS) is a division of the Wits Health Consortium (WHC) of the School of Pathology. The main …

SAINT-PREX, Switzerland & ROSEVILLE, Minnesota – (BUSINESS WIRE) – Ferring Pharmaceuticals and Rebiotix, a Ferring Company, today presented the results of the pivotal phase 3 PUNCH â„¢ CD3 clinical trial, demonstrating superior efficacy and consistent safety of single-dose RBX2660 in reducing recurrence of Clostridioides difficile infection (CDI) compared to placebo. …

Overview Publish by : Source: Indica Labs and Ibex Dated: May 20, 2021 ALBUQUERQUE, NM and TEL AVIV, Israel – May 20, 2021 – Life Science Newswire – Indica Labs, an industry leader in quantitative digital pathology and image management solutions, and Ibex Medical Analytics, a pioneer in cancer diagnostics …

Intensity Therapeutics, Inc. (“Intensity”), a clinical-stage biotechnology company developing proprietary intratumoral products to kill tumors and increase recognition of cancers by the immune system, today announced two poster presentations at the occasion of the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting to be held virtually June 4-8. Title: …

WALTHAM, Massachusetts, May 19, 2021 / PRNewswire / – Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotechnology company focused on developing therapies for difficult-to-treat hematologic diseases, today announces that three abstracts containing data on PEPAXTO® (melphalan flufenamide, also known as melflufen) in relapsed refractory multiple myeloma, have been accepted …

Blocked blood vessels in the brains of stroke patients prevent oxygen-rich blood from reaching cells, causing serious damage. Plants and some microbes produce oxygen through photosynthesis. What if there was a way to get photosynthesis to happen in patients’ brains? Now researchers report in ACS ‘ Nano Letters did just …

Dr Reddy’s Laboratories have entered into a voluntary, non-exclusive, royalty-free license agreement with the US pharmaceutical company Eli Lilly and Company for the manufacture and sale of the drug, baricitinib. Baricitinib has received a ‘restricted emergency use authorization’ from the Ministry of Health’s central standard drug control organization for use …

Chronic Obstructive Pulmonary Disease (COPD) is a disease caused by smoking that reduces lung function and causes difficulty breathing. It is the third leading cause of death in the world. Current treatments for COPD only affect the symptoms, not the progression. Identifying who will get COPD before they get it …

Image: Anti-COVID-19 drug contributes to faster recovery in hospital patients and reduces dependence on supplemental oxygen (Photo courtesy of DNA India) Anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been shown to promote faster recovery in hospital patients and reduce dependence on supplemental oxygen in clinical trials. 2-DG’s anti-COVID …

CAMBRIDGE, Mass .– (BUSINESS WIRE) –Scholar rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious conditions in which protein growth factors play a fundamental role, today announced that the results of its Phase 1 safety trial and the pharmacological profile of apitemograb in healthy volunteers were …

BOSTON–(BUSINESS WIRE) – Continuing their family’s deep commitment to beating pancreatic cancer, Judith B. Hale, her son, Robert T. Hale, Jr., and his wife, Karen Hale, have pledged an additional $ 50 million to Dana- Farber Cancer Institute. This donation, one of the largest one-time gifts in the history of …

CHICAGO, May 11, 2021 / PRNewswire / – Civis Analytics, an innovative data science firm at the intersection of public good and best scientific practice, today announced the results of a experience to scientifically determine the most compelling message for Americans most likely to be uncertain about COVID-19 vaccination. The …

Heligenics, Inc. today announced a new collaboration with the Jackson Laboratory. This joint project will make available the functional output of variants of unknown significance in a key part of the ERBB2 gene via the JAX clinical knowledge base, a digital resource that connects clinicians and researchers around the world …

(Boston) – Chronic obstructive pulmonary disease (COPD) is a disease caused by smoking that reduces lung function and causes difficulty breathing. It is the third leading cause of death in the world. Current treatments for COPD only affect the symptoms, not the progression. Identifying who will get COPD before they …

GLASGOW, Scotland – (BUSINESS WIRE) – OracleBio today announced the launch of the company’s GCP image analysis services. This latest service offering strengthens the company’s position as a world leader in quantitative digital pathology, thus expanding the company’s position in the clinical market. OracleBio’s new service offering generates quantitative image …